approval
saveVANFLYTA (QUIZARTINIB DIHYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: DAIICHI SANKYO INC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 3
- patent expirylaninamivir: Daiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))Apr 24, 2026
- drug expirylaninamivir: Daiichi Sankyo Co Ltd — laninamivir (Drug Expiry (Japan))Apr 24, 2026
- phase 1 completionraludotatug deruxtecan: Daiichi Sankyo Co Ltd — raludotatug deruxtecan (Phase I Trial Completion)Apr 30, 2026
comments(0)
5-min edit window · permanent after that